• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Stemgent

Health IT Catch-22: Electronic prescriptions could mean simultaneous reward and penalty for some providers | Funding Roundup

June 14, 2011 By MassDevice staff Leave a Comment

Funding

Damned if you do, damned if you don’t. That’s the predicament many providers find themselves in with the two current CMS e-prescription initiatives.

Medicare legislation passed in the Medicare Improvements for Patients and Providers Act of 2008 authorized the Centers for Medicare and Medicaid Services to offer incentives for meeting e-prescribing requirements, but providers who meet the standards for those rewards may still be penalized if they do not meet the threshold of sending at least 10 ePrescriptions between January 1 and June 30 of 2011.

Filed Under: Business/Financial News, News Well Tagged With: Gelesis Inc., HTG Inc., Remedent Inc., Spectra Analysis Instruments Inc., Stemgent, Universal Hospital Services Inc., Venture Capital/Private Equity

Cambridge Endo and Stemgent bring in several million in new funding rounds

May 18, 2010 By MassDevice staff Leave a Comment

Cambridge Endo, Stemgent logos

Cambridge Endoscopic Devices Inc. and Stemgent Inc. each made quick gains from multi-million dollar equity offerings that opened April 30.

Cambridge Endo, an endoscopic surgical tool maker based in Framingham, Mass., sold to one individual $3 million of a $7.5 million offering, according to Securities & Exchange Commission filings. CEO Woojin Lee and directors Walter Winshall and Phil Henderson were listed as principals in the deal.

Filed Under: Biotech, Business/Financial News, Endoscopic, News Well, Stem Cells Tagged With: Cambridge Endoscopic Devices Inc., Stemgent

Stemgent, Miltenyi Biotec ink strategic alliance

May 4, 2010 By MassDevice staff Leave a Comment

Stemgent, MACs logos

Stemgent Inc. and Germany-based Miltenyi Biotec inked a strategic partnership deal that will see the firms co-develop and market stem cell products.

Under the terms of the agreement, Miltenyi Biotec will be responsible for the overseas marketing and sale of Stemgent’s existing stem cell reagents, antibodies and other products, with Stemgent continuing to serve its U.S. customers. Both companies will begin to jointly develop new products, which Miltenyi Biotec will then commercialize.

Filed Under: Biotech, Business/Financial News, News Well, Stem Cells Tagged With: Miltenyi Biotec, Stemgent

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS